Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Frontiers in Molecular Biosciences|October 9, 2020
Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic CoronavirusesLuca Vangelista, Massimiliano SecchiViruses|November 11, 2022
Rational Engineering of a Sub-Picomolar HIV-1 BlockerMassimiliano Secchi, Luca VangelistaScientific Reports|February 1, 2018
Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockersMassimiliano Secchi, Valentina Grampa, Luca VangelistaVaccine|February 5, 2008
Rational design of novel HIV-1 entry inhibitors by RANTES engineeringLuca Vangelista, Massimiliano Secchi, Paolo LussoProtein Expression and Purification|July 4, 2009
The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutantsMassimiliano Secchi, Qiang Xu, Paolo Lusso, et al.Antimicrobial Agents and Chemotherapy|August 13, 2014
Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5Massimiliano Secchi, Lia Vassena, Sébastien Morin, et al.Antimicrobial Agents and Chemotherapy|May 19, 2010
Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockersLuca Vangelista, Massimiliano Secchi, Xiaowen Liu, et al.Chemistry & Biology|December 25, 2012
Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptidesMassimiliano Secchi, Renato Longhi, Lia Vassena, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 5, 2011
Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activityPaolo Lusso, Luca Vangelista, Raffaello Cimbro, et al.International Archives of Allergy and Immunology|August 14, 2003
Current progress in the understanding of IgE-FcepsilonRI interactionLuca VangelistaPageof 5